Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
29 Nov 2016 - 30 Nov 2016

Cell Therapy Manufacturing & Gene Therapy, Amsterdam

15 Nov 2016 - 16 Nov 2016

Stifel Healthcare Conference 2016 – New York, NY, USA

07 Nov 2016 - 09 Nov 2016

BioEurope, Cologne, Germany

03 Nov 2016 - 04 Nov 2016

2nd Annual Cell & Gene Therapy Congress, London, UK

18 Oct 2016 - 21 Oct 2016

European Society of Gene and Cell Therapy (ESGCT), Florence, Italy

13 October 2016

GenSight Biologics reports its cash position as of September 30, 2016

05 Oct 2016 - 08 Oct 2016

European Association for Vision and Eye Research, EVER, Nice, France

05 Oct 2016 - 07 Oct 2016

Cell&Gene Meeting on the mesa, La Jolla (CA), USA

21 Sep 2016 - 22 Sep 2016

Cell&Gene Therapy Europe, Berlin, Germany

08 September 2016

GenSight Biologics receives approval to include teenage patients in RESCUE and REVERSE Phase III trials with GS010 in Leber’s Hereditary Optic Neuropathy

  • View previous 9 articles
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page